Ezetimibe: Its Novel Effects on the Prevention and the Treatment of Cholesterol Gallstones and Nonalcoholic Fatty Liver Disease

The cholesterol absorption inhibitor ezetimibe can significantly reduce plasma cholesterol concentrations by inhibiting the Niemann-Pick C1-like 1 protein (NPC1L1), an intestinal sterol influx transporter that can actively facilitate the uptake of cholesterol for intestinal absorption. Unexpectedly,...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bari, Ornella, Neuschwander-Tetri, Brent A., Liu, Min, Portincasa, Piero, Wang, David Q.-H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216277/
https://www.ncbi.nlm.nih.gov/pubmed/22132342
http://dx.doi.org/10.1155/2012/302847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216277/
https://www.ncbi.nlm.nih.gov/pubmed/22132342
http://dx.doi.org/10.1155/2012/302847

Ejemplares similares